Innovations Abound - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Innovations Abound

Pharmaceutical Technology

Here's a look at some of the most interesting and thematic responses you—our readers—provided for Pharmaceutical Technology's anniversary survey of industry advances and directions.

Which events significantly affected or caused changes in pharmaceutical manufacturing?
"My graduation from college."

"Better chemistry," "gene technology," and "train(ing) dogs to sniff counterfeit drugs" will impact the future direction of pharmaceutical manufacturing.

The rationalization of small-molecule manufacturing facilities in APIs.
"Is the leading edge of pharma."

On the use of information technology:
"There is no replacement for an advanced and validated computerized system."

When it comes to formulation development and manufacturing practices.
"The advice from our management is to have 50% of our workload outsourced—and especially routine work."

Thanks to advanced analytical technologies in NIR.
"(we) don't actually need to prepare the sample tediously."

With regard to the GMPs for the 21st century.
"It's been a long time since 1978, and it is time to update."

"...Most companies have found a way around..."
21 CFR Part 11 regulation.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here